Yesway, Inc. Reports Second Quarter 2026 Financial Results

Yesway, Inc. (Nasdaq: YSWY) reported Q2 2026 results for the quarter ended June 30, 2026. Net income rose to $29.7M from $24.2M and Adjusted EBITDA increased 35.0% to $70.9M. Same-store inside merchandise sales rose 1.2% and same-store fuel gallons 1.4%. The company raised full-year 2026 Adjusted EBITDA outlook to $235M-$245M.

Original reporting
Published Aug 13, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 11:58 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$YSWY
Bullish
high confidence
Mentioned
$YSWY
Relevance
9/10
AlphAI data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$YSWYBullishHigh
01

Why it matters

The combination of YoY growth in net income and Adjusted EBITDA, improved same-store metrics, and a higher full-year Adjusted EBITDA range provides a clear basis for earnings estimate revisions and near-term positioning.

02

Market read

This is a direct earnings and guidance update with quantified operating drivers (fuel margin, inside merchandise margin, same-store growth) and a raised full-year EBITDA range.

03

What to watch

The article notes expected sale of 29 stores by year-end; traders may discount near-term performance quality if margins normalize post-sale or if execution risk emerges.

Relevance 9/10Novelty 9/10Timing: pre-market today (Aug. 13, 2026) earnings release

Background

Yesway is a US convenience store operator with a fuel and inside merchandise mix, reporting Q2 2026 results and updating its full-year Adjusted EBITDA outlook.

Company-level read

Ticker impact

$YSWYBullishHigh confidence
Context

Yesway reported Q2 2026 results with Adjusted EBITDA up 35% YoY to $70.9M and raised full-year 2026 Adjusted EBITDA outlook to $235M-$245M.

Expected impact

Likely positive bias for the next trading session and into earnings revisions, assuming no guidance skepticism.

Evidence & confidence

The article discloses multiple quantified operating metrics (EBITDA, net income, margins) and a specific updated full-year outlook range, which are direct inputs to forward estimates.

Market effects

Reinforces strength in convenience retail operators’ fuel and inside merchandise margin resilience, potentially supporting sector sentiment.

No specific regional macro impact beyond Yesway’s Iowa and Kansas portfolio sale expectation.

Limited global relevance; primarily a US small-cap retail earnings and guidance update.

Counterpoint

The outlook raise may already be partially anticipated; investors may focus on sustainability of fuel margin and the impact of the Iowa and Kansas store divestiture.

Key entities

  • Yesway, Inc.

    Reported Q2 2026 financial results and increased full-year 2026 Adjusted EBITDA outlook.

  • Thomas N. Trkla

    Chairman, President and CEO who attributed performance to fuel and inside merchandise execution.

Related articles

$YSWYHighAI 8/10

Yesway (YSWY) Q2 2026 Earnings Call Transcript

Yesway (YSWY) reported Q2 2026 earnings with adjusted EBITDA of $70.9M, up 35% YoY, driven by fuel and merchandise sales growth. Fuel margin was 52.6 cents per gallon, up 27.4% YoY. Net income rose to $29.7M from $24.2M. The company raised full-year EBITDA guidance to $235M-$245M and plans to open 6-8 new stores. Management highlighted strong diesel sales and cost efficiencies, but noted risks from fuel price volatility and economic conditions.

$YSWYMed

Yesway, Inc. (YSWY): Results of Operations and Financial Condition

Yesway, Inc. (YSWY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Yesway, Inc. Reports Second Quarter 2026 Financial Results Achieved record Store Contribution, driven by increases in fuel margin and inside merchandise margin from same-store sales and increases in fuel gallons and inside merchandise sales from new stores Delivered

$YSWYMedAI 9/10

Yesway Swings To Profit In Q1, Shares Up

Yesway, Inc. (YSWY) reported a swing to profit in Q1, with net income of $30.24 million versus a $5.63 million loss a year earlier, according to the company. Revenue rose to $683.63 million from $600.32 million, and adjusted EBITDA increased to $59.2 million from $27.8 million. For 2026, it expects inside same-store merchandise sales growth of 1.25%-3.25% and adjusted EBITDA of $210-$220 million, plus 6-8 new stores.

$HCWCLow

HEALTHY CHOICE WELLNESS CORP. (HCWC): Results of Operations and Financial Condition

HEALTHY CHOICE WELLNESS CORP. (HCWC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF HOST DIGITAL INFRASTRUCTURE LLC The following discussion should be read together with Host Digital Infrastructure LLC’s (the “Company”, “we”, “our” and “us”) financial statements

$AMZNMedAI 8/10

Amazon’s Jassy Bets on Trillion-Dollar AWS Future as AI Demand Outruns Even $220 Billion Spend

Amazon CEO Andy Jassy forecasted AWS could generate $1 trillion in annual revenue, citing strong AI demand. AWS's current annualized revenue is $169 billion. Amazon raised its 2026 capital expenditure forecast to $220 billion, up from $200 billion, to meet infrastructure needs. Jassy noted supply shortages will persist despite increased spending, with AI-specific revenue run rate exceeding $25 billion.

$MDTHighAI 8/10

Should You Buy Medtronic Stock as Its Hugo Surgical Robot Gains Ground?

Medtronic (MDT) shares are down 3% this year, but the company's Hugo robotic-assisted surgery system is gaining market share. The FDA approved Hugo for urological procedures, and Medtronic submitted new filings for broader use. Q1 2027 revenue was $9.8B, up 13.7% YoY, with EPS of $1.14, up 40.7%. The company raised full-year guidance and is on track to become a Dividend King. Medtronic's dividend yield is 3.06%, and it is expanding in cardiac and spinal technologies.